New cancer treatment stops aggressive sarcomas

After all standard treatments had failed, a new cancer treatment. NeoPlas, has stopped the growth of aggressive sarcomas in two recent  patients. These results are similar to the new protocol's previous  success against several cancers, including melanoma, pancreatic, colon,  mesothelioma and other sarcomas.

One of the patients is an 18-year-old with malignant fibrous  histiocytoma that arose in the largest bone of his leg. The cancer  spread throughout his lungs, despite aggressive surgery that replaced  most of his leg with metal implants. The second patient was losing a  battle with desmoplastic small round-cell tumor, a very rare and  aggressive cancer. After undergoing multiple surgical procedures and  different chemotherapy regimens, the DSRCT still progressed and spread  through the abdomen.

After eight weeks of the NeoPlas regimen, scans showed that both  patients' cancers had stopped their growth, and some tumors actually had  regressed. Additionally, both are tolerating the treatment well and are  able to carry on normal activities. US firm NeoPlas Innovation director  of research Stephen Cantrell commented: "these are early results and not  statistically valid yet. Still, the sarcomas as a group are so  aggressive and uniformly fatal that being able to stop their growth and  spread is very exciting. It's a major victory for these individuals, and  it mirrors the success we're seeing in the great majority of patients so  far."